Bröckelmann, Paul J.
ORCID: 0000-0001-9662-9900, Böll, Boris
ORCID: 0000-0002-6432-0981, Molin, Daniel, Schneider, Gundolf
ORCID: 0000-0001-6175-2554, Leppä, Sirpa
ORCID: 0000-0002-8265-511X, Meissner, Julia, Kamper, Peter, Hutchings, Martin, Christensen, Jacob H., Schnetzke, Ulf, Fuchs, Michael
ORCID: 0000-0003-3289-3272, Jablonski, Janina
ORCID: 0009-0007-2811-4762, Eichenauer, Dennis A.
ORCID: 0000-0002-1927-3514, von Tresckow, Bastian
ORCID: 0000-0003-1410-4487, Klapper, Wolfram
ORCID: 0000-0001-7208-4117, Kobe, Carsten
ORCID: 0000-0002-2909-0826, Borchmann, Peter
ORCID: 0000-0003-3782-2158 and Fosså, Alexander
ORCID: 0000-0002-4484-9319
(2025).
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patients.
HemaSphere, 9 (8).
pp. 1-5.
Wiley.
ISSN 2572-9241
Dietlein, Markus
ORCID: 0000-0003-0992-6099, Schmidt, Matthias
ORCID: 0000-0002-7519-8897, Drzezga, Alexander
ORCID: 0000-0001-6018-716X and Kobe, Carsten
ORCID: 0000-0002-2909-0826
(2025).
Radioiodine Therapy of Graves’ Disease in Women with Childbearing Potential and the Pre-Conceptional Counseling About Antithyroid Drugs.
Journal of Clinical Medicine, 14 (5).
MDPI.
ISSN 2077-0383
Heilinger, Jan
ORCID: 0009-0004-0026-824X, Roth, Katrin Sabine
ORCID: 0000-0002-3786-2777, Weis, Henning
ORCID: 0000-0001-8638-3281, Fink, Antonis, Weindler, Jasmin
ORCID: 0009-0001-8810-0617, Dietlein, Felix
ORCID: 0000-0002-6651-7155, Krapf, Philipp
ORCID: 0000-0003-1671-2443, Schomäcker, Klaus
ORCID: 0000-0003-2636-0058, Neumaier, Bernd
ORCID: 0000-0001-5425-3116, Dietlein, Markus
ORCID: 0000-0003-0992-6099, Drzezga, Alexander
ORCID: 0000-0001-6018-716X and Kobe, Carsten
ORCID: 0000-0002-2909-0826
(2025).
Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy.
EJNMMI Research, 15 (1).
pp. 1-8.
Springer Nature.
ISSN 2191-219X
Heilinger, Jan
ORCID: 0009-0004-0026-824X, Weindler, Jasmin, Roth, Katrin Sabine, Krapf, Philipp
ORCID: 0000-0003-1671-2443, Schomäcker, Klaus
ORCID: 0000-0003-2636-0058, Dietlein, Markus, Drzezga, Alexander
ORCID: 0000-0001-6018-716X and Kobe, Carsten
(2023).
Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer.
EJNMMI Research, 13 (1).
p. 83.
Springer Nature.
ISSN 2191-219X
Kobe, Carsten
ORCID: 0000-0002-2909-0826, Armand, Philippe, Borchmann, Sven
ORCID: 0000-0001-6662-6864, Collins, Graham P., Cottereau, Anne‐Segolene, Ferdinandus, Justin
ORCID: 0000-0002-3481-7997, Herrera, Alex F., Rossi, Davide, Plattel, Wouter J., Barrington, Sally F. and Hutchings, Martin
(2025).
Working towards harmonization of clinical trial reporting in Hodgkin lymphoma.
HemaSphere, 9 (8).
pp. 1-4.
Wiley.
ISSN 2572-9241
Rosenbrock, Johannes
ORCID: 0000-0003-3340-0556, Kaul, Helen, Oertel, Michael, Celik, Eren, Linde, Philipp
ORCID: 0000-0002-2813-1331, Fan, Jiaqi, Eichenauer, Dennis A.
ORCID: 0000-0002-1927-3514, Bröckelmann, Paul J.
ORCID: 0000-0001-9662-9900, von Tresckow, Bastian
ORCID: 0000-0003-1410-4487, Kobe, Carsten
ORCID: 0000-0002-2909-0826, Dietlein, Markus
ORCID: 0000-0003-0992-6099, Fuchs, Michael
ORCID: 0000-0003-3289-3272, Borchmann, Peter
ORCID: 0000-0003-3782-2158, Eich, Hans Theodor and Baues, Christian
(2024).
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma—An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group.
International journal of radiation oncology, biology, physics, 120 (5).
pp. 1344-1352.
Elsevier Science.
ISSN 0360-3016
Up a level